Novavax's updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming ...
Updated Sarah BranerThe premier global health authority has given Novavax’s updated COVID-19 shot a stamp of approval.The ...
Novavax (NASDAQ:NVAX) has agreed to settle a securities class action over its COVID-19 vaccine claims for $47M. The lawsuit was filed in 2021 by Sothinathan Sinnathurai in the U.S. District Court of ...
Listen to this article Gaithersburg-based Novavax Inc. Tuesday announced its Nuvaxovid XBB.1.5 COVID-19 vaccine (NVX-CoV2601) ...
A lot has changed with COVID-19 vaccines since they first debuted back in December 2020. We’ve seen a few hit the market, one ...
Novavax has been granted emergency use listing (EUL) by the World Health Organisation (WHO) for its updated form of the ...
"The WHO Emergency Use Listing of our updated protein-based non-mRNA COVID-19 vaccine enables expedited regulatory approvals for its 194 member states and UN procurement agencies, such as UNICEF, ...
Health Canada has authorized an adapted vaccine from Novavax to prevent COVID-19 in people age 12 and older.The vaccine uses ...
FDA Authorizes Updated Novavax COVID-19 Vaccine Formulated to Better Protect Against Currently Circulating Variants - ...
In this radio interview with John Batchelor, our conversation includes (1) the approval of the latest COVID vaccines; and (2) ...
Past doses of the COVID vaccine will not protect you against the current strains. Current available vaccines include ...
Novavax Inc (NASDAQ:NVAX) reported total revenue of $187 million for Q3 2023, a significant decrease from $735 million in the same period in 2022. The company reduced operating expenses by $950 ...
